Narmac, agreed this management team at the other company is a joke at best, They had the pharma and Biotech world in their hand way before the end of BETONMACE in 2019 and they cheaped out not doing an interm analysis to save a few million dollars  . They would have realized the trial was not powered enough and extended it knowing  how close  the results were in passing  the trial.Look where that took them now..... If DM had more than a pea brain he would realize if he actually passed the reigns  on to a new experience Biotech executive both ZEN and RVX would get huge respect and more money moved in the companies giving a realistic market cap for both companies and maybe an IPO and buyout .  We'll see if they can get a BP deal done at Zen to save both companies, who knows it could happen....